Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2013; 19(30): 4958-4965
Published online Aug 14, 2013. doi: 10.3748/wjg.v19.i30.4958
Published online Aug 14, 2013. doi: 10.3748/wjg.v19.i30.4958
Variables | Group | P value | |
A (n = 20) | B (n = 20) | ||
Age (yr) | 51.1 ± 8.5 | 49.7 ± 9.59 | 0.628 |
Gender (female) | 11 (55) | 12 (60) | 0.749 |
Alcohol | 3 (15) | 4 (20) | 0.677 |
Smoking | 4 (20) | 9 (45) | 0.091 |
BMI (kg/m2) | 21.56 ± 1.74 | 21.79 ± 2.2 | 0.716 |
Region (rural) | 9 (52.94) | 7 (36.84) | 0.332 |
Symptom index1 | 5 (25) | 5 (25) | - |
Acid exposure time | 0.52% ± 0.68% | 0.44% ± 0.8% | 0.719 |
Baseline BDI | 6.9 ± 2.22 | 7.35 ± 1.93 | 0.498 |
Time | Group A | Group B | P value1 |
Week 0 | 5.85 (5.09-6.61) | 6.10 (5.34-6.86) | 0.642 |
Week 1 | 4.90 (4.14-5.66) | 5.10 (4.34-5.86) | 0.709 |
Week 2 | 3.94 (3.08-4.80) | 3.90 (3.06-4.74) | 0.948 |
Week 3 | 3.76 (2.86-4.66) | 3.95 (3.10-4.80) | 0.755 |
Week 4 | 3.82 (2.96-4.68) | 3.90 (3.10-4.70) | 0.889 |
Week 5 | 3.18 (2.38-3.98) | 3.80 (3.05-4.55) | 0.259 |
Week 6 | 3.00 (2.21-3.79) | 3.95 (3.21-4.69) | 0.084 |
Week 7 | 2.89 (2.12-3.65) | 4.05 (3.33-4.77) | 0.031 |
Week 8 | 2.47 (1.68-3.27) | 4.37 (3.63-5.11) | 0.001 |
Variables | Group | P value | |
A (n = 20) | B (n = 20) | ||
Physical functioning | |||
Baseline | 42.01 ± 13.47 | 32.83 ± 17.06 | 0.211 |
End of treatment | 37.28 ± 12.76 | 38.42 ± 7.83 | 0.753 |
Role -physical | |||
Baseline | 31.51 ± 14.9 | 29.45 ± 15.51 | 0.670 |
End of treatment | 37.88 ± 10.16 | 39.02 ± 12.49 | 0.768 |
Role-emotional | |||
Baseline | 32.01 ± 12.12 | 38.39 ± 12.68 | 0.112 |
End of treatment | 36.99 ± 12.62 | 30.14 ± 16.95 | 0.182 |
Social functioning | |||
Baseline | 37.95 ± 14.06 | 33.82 ± 13.90 | 0.356 |
End of treatment | 36.41 ± 13.03 | 30.07 ± 12.83 | 0.151 |
Body pain | |||
Baseline | 34.94 ± 14.39 | 30.13 ± 12.09 | 0.260 |
End of treatment | 52.37 ± 17.00 | 41.32 ± 12.34 | 0.031 |
General health perceptions | |||
Baseline | 38.63 ± 11.66 | 31.82 ± 12.94 | 0.088 |
End of treatment | 47.95 ± 18.58 | 31.84 ± 16.84 | 0.010 |
Mental health | |||
Baseline | 38.82 ± 14.72 | 39.20 ± 10.67 | 0.927 |
End of treatment | 44.69 ± 10.79 | 38.88 ± 10.50 | 0.111 |
Energy/vitality | |||
Baseline | 38.08 ± 12.50 | 34.39 ± 12.64 | 0.360 |
End of treatment | 42.95 ± 15.32 | 35.14 ± 10.87 | 0.084 |
- Citation: Park SW, Lee H, Lee HJ, Park JC, Shin SK, Lee SK, Lee YC, Kim JE. Low-dose amitriptyline combined with proton pump inhibitor for functional chest pain. World J Gastroenterol 2013; 19(30): 4958-4965
- URL: https://www.wjgnet.com/1007-9327/full/v19/i30/4958.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i30.4958